French Biomarker Company TcLand Names Huriez Chairman and CEO
TcLand S.A. (Nantes, France, www.tcland-biotech.com) has named Alain Huriez, MD, one of the company's co-founders, as Chairman and CEO.
TcLand S.A. (Nantes, France, www.tcland-biotech.com) has named Alain Huriez, MD, one of the company’s co-founders, as Chairman and CEO. Past roles held by Huriez include vice president of Quintiles Europe (in charge of the firm’s biotechnology consulting group) and CEO of Neovacs SA. TcLand developed diagnostic biomarkers and therapeutic molecules for patients with immune disorders, and runs immunological tests for biopharmaceutical companies conducting clinical trials.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
